Valsartan And Hydrochlorothiazide
Product Images NDC 68258-6095

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 68258-6095). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Ndc 68258-6095-xx (Ndc 68258 6095 Xx Novartis)

Ndc 68258-6095-xx (Ndc 68258 6095 Xx Novartis)
This text provides information on bulk source data for a medicine produced by Novartis Pharmaceuticals Corp. The medicine is a dark red oval tablet with the imprint CG/HHH and is dispensed in a tight/light resistant container. It contains 160 mg of Valsartan USP and 12.5 mg of Hydrochlorothiazide USP. The medicine may cause drowsiness, dizziness or headache and should be taken orally once daily as directed by a doctor. The text also provides the NDC, product ID, pedigree number, MFR.LOT number, and warnings regarding pregnancy and children's reach. The summary ends with information on packaging by Dispensing Solutions of Santa Ana, CA.*
FDA Label Image

Ndc 68258-6096-xx (Ndc 68258 6096 Xx Novartis)

Ndc 68258-6096-xx (Ndc 68258 6096 Xx Novartis)
This is a bulk source data sheet for a pharmaceutical product that contains hydrochlorothiazide and valsartan, manufactured by Novartis Pharmaceuticals Corp. The product is an oval-shaped tablet that is brown in color and has a slightly convex shape. It is labeled with the product ID and the NDC, which is 00781-5950-10. The drug is packed in a tight/light resistant container and should be taken orally once daily as directed by a doctor. The lot number is XXXXXX, and the pedigree number is 046-834619. The text includes warnings such as possible side effects and the risk of fetal harm if taken during pregnancy. The product is packaged in Santa Ana, CA, by Dispensing Solution.*
FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Valsartan Hct 1)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Valsartan Hct 1)
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Valsartan Hct 2)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Valsartan Hct 2)
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Valsartan Hct 3)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Valsartan Hct 3)
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Valsartan Hct 4)

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Valsartan Hct 4)
FDA Label Image

Valsartan Chemical Structure (Valsartan Hct 5)

Valsartan Chemical Structure (Valsartan Hct 5)
FDA Label Image

Hydrochlorothiazide Chemical Structure (Valsartan Hct 6)

Hydrochlorothiazide Chemical Structure (Valsartan Hct 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.